Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

No Participants in Chinese Phase I Clinical Trial of HIV Vaccine Showing Ill Effects, Experts Say

April 3, 2006

None of the 49 participants taking an experimental HIV vaccine in a Phase I clinical trial launched last year in Nanning, China, is showing ill effects, according to clinical observation, Xinhuanet reports. Experts have been visiting the volunteers in groups and have visited all but 15 of the volunteers so far. The trial participants, ages 18 to 50, were given either a single experimental HIV vaccine or a combined vaccine between March 2005 and October 2005. In the coming months, experts will visit the final group and receive the recommendations of a panel chosen to evaluate the data. The Ministry of Science and Technology and the State Food and Drug Administration will decide whether to go forward with a Phase II trial of the vaccine based on the outcome of the assessment (Xinhuanet, 3/30).

Back to other news for April 3, 2006


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2006 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement